Inmed to present at h.c. wainwright 25th annual global investment conference

Vancouver, british columbia--(newsfile corp. - september 7, 2023) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a leader in the pharmaceutical research, development, manufacturing, and commercialization of rare cannabinoids and cannabinoid analogs, today announce that the company will be participating in the h.c. wainwright global investment conference, which takes place september 11-13, 2023, in new york city.
INM Ratings Summary
INM Quant Ranking